发明名称 |
TREATMENT OF LUPUS NEPHRITIS USING LAQUINIMOD |
摘要 |
<p>This invention provides a method of treating a subject afflicted with active lupus nephritis comprising periodically administering to the subject an amount of laqumimod or pharmaceutically acceptable salt thereof effective to treat the subject This invention also provides laquinimod or pharmaceutically acceptable salt thereof for use in treating a subject afflicted with active lupus nephritis This invention further provides a pharmaceutical composition comprising an amount of laquinimod or pharmaceutically acceptable salt thereof for use in treating a subject afflicted with active lupus nephritis</p> |
申请公布号 |
CA2791691(A1) |
申请公布日期 |
2011.09.09 |
申请号 |
CA20112791691 |
申请日期 |
2011.03.02 |
申请人 |
TEVA PHARMACEUTICAL INDUSTRIES LTD. |
发明人 |
HAVIV, ASI;TARCIC, NORA |
分类号 |
A61K31/4704;A61K31/5377;A61P13/12;A61P29/00;A61P37/06 |
主分类号 |
A61K31/4704 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|